Skip to the page

Data / Form D filings / Insigna, Inc.

Insigna, Inc.: Form D filings

Insigna, Inc., a pharmaceuticals company in Champaign, IL, filed 6 Form D notices with the SEC between 2019 and 2025. The latest, on July 8, 2025, reports $4 million sold of an offering with no set size to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2109 S. Oak St, Suite 100A, Champaign, IL, 61820
Phone
(833) 565-4771
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1780356

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 8, 2025AmendmentIndefinite$4,000,0322Jan 22, 2025sec.gov
Feb 18, 2025New noticeIndefinite$2,000,0160Jan 22, 2025sec.gov
Mar 10, 2023AmendmentIndefinite$1,166,9277Nov 23, 2022sec.gov
Dec 27, 2022New noticeIndefinite$96,9834Nov 23, 2022sec.gov
Aug 10, 2022New noticeIndefinite$2,000,0001Aug 8, 2022sec.gov
Jun 21, 2019New notice$2,000,000$1,368,400$631,60018May 23, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Byron Alexandrovich WittenbergExecutive Officer, Director
CheMyong Jay KoExecutive Officer, Director

Every Form D from the week of Jul 7, 2025 · All recent filings in Illinois · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Insigna, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.